UBS Group’s ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN MLPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.58M Buy
+65,725
New +$4.65M ﹤0.01% 4248
2026
Q1
Sell
-55,460
Closed -$3.24M 10918
2025
Q4
$3.24M Buy
+55,460
New +$3.16M ﹤0.01% 4477
2025
Q2
Sell
-30
Closed -$2.05K 10625
2025
Q1
$2.05K Buy
+30
New +$1.98K ﹤0.01% 9405
2024
Q4
Sell
-147
Closed -$8.46K 10225
2024
Q3
$8.46K Buy
+147
New +$8.44K ﹤0.01% 7837
2023
Q1
Sell
-90
Closed -$3.71K 10056
2022
Q4
$3.71K Sell
90
-301
-77% -$12.5K ﹤0.01% 9464
2022
Q3
$15K Hold
391
﹤0.01% 7812
2022
Q2
$13K Buy
+391
New +$15.5K ﹤0.01% 7522

Other funds holding MLPR

UBS Group's MLPR Position: Q2 2026 in Review

UBS Group opened a new position in ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN (MLPR) in Q2 2026: 65,725 shares worth $4.58M. The stake represents ﹤0.01% of the portfolio and ranks #4248 among its holdings. This is a return to the name: UBS Group previously reported a position in MLPR as recently as Q4 2025.

UBS Group first reported a position in MLPR in Q2 2022 and has held it in 7 quarters since. 2 funds tracked by Wall St. Rank hold MLPR as of Q2 2026.

  • UBS Group held 65,725 shares of ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN worth $4.58M as of Q2 2026.
  • ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN was a new UBS Group position in Q2 2026.
  • ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4248 holding.
  • UBS Group first reported a position in ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN in Q2 2022 and has held it in 7 quarters since.
  • 2 funds tracked by Wall St. Rank held ETRACS Quarterly Pay 1.5x Leveraged Alerian MLP Index ETN as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.